We assessed the possible protective effects of N-acetylcysteine (NAC) against toxic damage in the rat colon. Two doses of NAC (20 mg/kg and 100 mg/kg) given for 2 days and 7 days after acetic acid administration (to induce colitis) were tested. NAC was dissolved in saline and administered locally (intracolonic), systemically (intraperitoneal) or in a combination (intracolonic and intraperitoneal). Several parameters, including macroscopic and histopathological scores and myeloperoxidase, glutathione and nitric oxide concentrations were measured using standard assay procedures. Treatment with 100 mg/kg NAC for 7 days significantly decreased tissue myeloperoxidase, glutathione and nitric oxide concentrations. The 20 mg/kg dose had no protective effects. The data indicate that NAC substantially reduced the degree of colonic injury, probably by regulating free radical production and inhibiting inflammation. It may, therefore, have a role in the treatment of inflammatory bowel disease.
Introduction
Inflammatory bowel disease (IBD) is a chronic recurrent disease of the digestive tract. 1, 2 The aetiology of IBD remains unknown, although several aetiopathogenic mechanisms contributing to tissue injury have been proposed; these involve the synthesis and release of different pro-inflammatory mediators, including reactive oxygen and nitrogen metabolites, eicosanoids, plateletactivating factor and cytokines. 2, 3 Evidence from clinical and experimental settings supports a crucial role for neutrophils in the tissue ulceration and inflammation, usually referred to as ulcerative colitis or Crohn's disease, that occurs with IBD. 4 Furthermore, antioxidant enzymatic systems, such as superoxide dismutase, catalase and glutathione peroxidase, have been reported to be deficient in patients suffering from IBD. 4 These mediators all contribute to the pathogenic cascade that initiates and perpetuates the inflammatory response in the gut. The best strategy to down-regulate intestinal inflammation effectively is, therefore, to interfere with multiple stages of the inflammatory cascade, preferably with a single drug treatment. It has been suggested that the imbalance between pro-oxidant and antioxidant mechanisms in IBD may be controlled by antioxidant therapy. The antioxidant N-acetylcysteine (NAC) is a small molecule containing a thiol group. It is freely filterable, has ready access to intracellular compartments 5 and has been widely used as an antioxidant both in vivo and in vitro. The diversity of pharmacological applications of NAC is regulated by the chemical properties of the cysteinyl thiol group of molecules, since the ability of reduced thiol groups to scavenge oxygen-free radicals is well established. 5 NAC is known to act by raising the intracellular concentrations of cysteine and hence reducing the concentration of glutathione (GSH) and/or scavenging radical oxygen species (ROS) .
Given that increased free radical concentrations are associated with experimental colitis, we hypothesized that NAC treatment might normalize the concentrations of oxidative stress markers.
We aimed to determine whether NAC could protect the colonic mucosa against an inflammatory attack in a rat model of colitis induced by intracolonic administration of acetic acid. We also investigated the effect of two doses of NAC and three administration methods on intestinal inflammation in the same model.
Materials and methods

MATERIALS
N-Acetylcysteine was kindly donated by Bilim Ilac San. ve Tic A.S. (Istanbul, Turkey). All other reagents were obtained from Sigma (Deisenhofen, Germany) unless stated otherwise.
ANIMALS
Swiss albino rats of both sexes weighing 190 -210 g were fasted for 12 h before the experiments, but were allowed free access to water. Rats were kept in a room at a constant temperature of 21 ºC and with a 12-h light/dark cycle. Rats were housed in individual wire-bottomed cages and fed a standard chow pellet diet.
The Ege University School of Medicine Animal Care and Use Committee approved all of the experimental protocols.
INDUCTION OF COLITIS
Acid-induced inflammation, as described previously, 6 was used to simulate colitis in the rats. Briefly, fasted rats were lightly anaesthetized with isoflurane and a 6-F catheter inserted into the colon, via the anus, to the splenic flexura (6 cm from the anus). Acetic acid (4%; pH 2.4) was administered through the catheter (total volume, 1 ml). The rats were kept in the Trendelenburg position for 1 min to avoid reflux while they recovered from the anaesthetic. They were then returned to their cage.
EXPERIMENTAL GROUPS AND TREATMENTS
The rats were divided randomly into four main groups: short-term (2 days) low-dose (20 mg/kg) NAC group; short-term high-dose (100 mg/kg) NAC group; long-term (7 days), low-dose NAC group; and longterm high-dose NAC group. All NAC groups received daily treatment in two equal doses given 12 h apart. The rats were further subdivided depending on the route of NAC administration: intracolonic (locally); intraperitoneal (systemically); and a combination (intracolonic and intraperitoneal administration). Five rats were allocated to each group; the treatments received and group number allocated are shown in Table 1 . Control rats received vehicle (1 ml saline, intraperitoneally) twice daily for either 2 days or 7 days. Age-matched, untreated rats served as healthy controls.
Rats in the short-term and long-term treatment groups were killed 48 h and 7 days after acetic acid administration, respectively. The abdomen was opened by a midline incision. The descending colon was removed, freed from surrounding tissues, opened along the antimesenteric border, rinsed, weighed, analysed for colonic damage and processed for histological and biochemical analyses. Samples were stored at -70 ºC prior to analysis.
MACROSCOPIC ASSESSMENT OF COLONIC DAMAGE
Colonic damage was evaluated using a modified scoring system ( Table 2) . 7 The thickness of the colonic tissue was measured using a 1/100 mm sensitive PROFI/Qualitatprecision micrometer.
HISTOLOGICAL ANALYSIS USING LIGHT MICROSCOPY
Small pieces of colon tissue were placed in 10% (v/v) formalin solution, dehydrated in ethanol and processed routinely by embedding in paraffin. Tissue sections (7 µm) were deparaffinized with xylene, stained with haematoxylin and eosin, and examined under a light microscope (Olympus-BH-2, Olympus Corporation, Kyoto, Japan). An experienced histologist who was unaware of the treatment regimen scored the samples according to the criteria given in Table 3 .
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Short-term therapy (2 days)
Controls (no treatment) 1 -
Systemic therapy (intraperitoneal) 4 7
Combined therapy (intracolonic and intraperitoneal) 5 8
Long-term therapy (7 days)
Controls (no treatment) 9 -Saline 10 -Local therapy (intracolonic) 11 14 Systemic therapy (intraperitoneal) 12 15 Combined therapy (intracolonic and intraperitoneal) 13 16 Chronic control group (experimental colitis group, not treated) -17 Effects of N-acetylcysteine on experimental colitis 
MYELOPEROXIDASE ACTIVITY
Myeloperoxidase (MPO) activity was measured in colon tissue using a method similar to that described by Krawisz et al. 8 Mucosal samples were homogenized in 50 mM potassium phosphate buffer (PB, pH 6.0), and centrifuged at 41 400 g for 10 min; pellets were suspended in 50 mM PB containing 0.5% hexadecyltrimethylammonium bromide. After three freeze/thaw cycles, with sonication between each cycle, the samples were centrifuged at 41 400 g for 10 min. Aliquots (0.3 ml) were added to 2.3 ml of reaction mixture containing 50 mM PB, 0.68 mM o-dianisidine, and 20 mM H 2 O 2 solution. One unit of enzyme activity was defined as the concentration of MPO that caused a change in absorbance measured using a spectrophotometer (Shimadzu 160 A UV-Vis spectrophotometer, Shimadzu Corporation, Kyoto, Japan) at 460 nm for 3 min. MPO activity was expressed as U/g tissue.
MEASUREMENT OF GLUTATHIONE CONCENTRATION
The Bioxytech ® GSH-400 TM colorimetric assay (Oxis International Inc., Portland, OR, USA) was used according to the manufacturer's instructions to measure GSH (γglutamylcysteinylglycine) concentration. The absorbance measured at 400 nm was converted to GSH concentration using a standard curve. Results were expressed as µmol GSH/g tissue.
MEASUREMENT OF NITRIC OXIDE CONCENTRATION
Tissue nitric oxide (NO) concentration was measured using the Bioxytech ® nitric oxide colorimetric non-enzymatic assay kit (Oxis International Inc.) according to manufacturer's instructions. Absorbance of the resulting chromophore was measured at 540 nm spectrophotometrically and converted to NO concentration using a standard absorbance-concentration curve. Results were expressed µmol nitrite/g tissue.
STATISTICAL ANALYSIS
The number of rats studied is represented by n. For the histological analyses, the figures shown are representative of at least three experiments performed on different days. For each group, histological samples obtained from three distinct rats were used for histological analysis. All values are expressed as mean ± SEM and a P-value < 0.05 was considered significant.
Results
MACROSCOPIC ASSESSMENT OF THE COLON
The effects of NAC treatment on tissue thickness and macroscopic score were significantly different (P < 0.05) between the short-(groups 1 -8) and long-term (groups 9 -17) NAC treatment groups (Figs 1 and 2 ). An increased thickness of the colon wall in the long-term low-dose groups was found when compared with the chronic control group: 0.79 ± 0.08 mm (group 11), 0.64 ± 0.03 mm (group 12), 0.59 ± 0.03 mm (group 13) versus 0.37 ± 0.01 mm (group 17). Nevertheless, tissue thickness was reduced in the long-term, high-dose groups: 0.49 ± 0.08 mm (group 14), 0.47 ± 0.08 mm (group 15), 0.44 ± 0.10 mm (group 16) versus 0.37 ± 0.01 mm (group 17). The most notable decrease was in the long-term high-dose combined therapy group (group 16) compared with the other groups. The effect of a high dose of NAC on tissue thickness in the short-term groups (groups 6 -8) paralleled those of the corresponding longterm groups (groups 14 -16), but with a lesser effect (Figs 1 and 2) .
The macroscopic score was elevated in the short-(groups 3 -8) and long-term (groups 11 -16) groups compared with untreated animals (groups 1, 2, 9, 10 and 17). High-dose FIGURE 2: The relationship between the macroscopic score and tissue thickness in rats with experimentally induced colitis treated with N-acetylcysteine. Error bars show the 95% confidence interval of the mean and the circles show the mean per treatment group. The treatments received by each group (1 -17) are shown in Table 1 NAC therapy significantly (P < 0.05) reduced the scores in both the short-and long-term groups (Fig. 2 ).
HISTOLOGICAL RESULTS
Short-term NAC administration did not alleviate the symptoms of experimentally induced colitis, such as complete ulceration of the mucosa, oedema, loss of goblet cells and intense diffuse transmural inflammatory infiltrates (such symptoms are illustrated in a control sample, Fig. 3B ). The colons from rats that received long-term therapy with high-dose NAC (groups 14 -16) showed wellpreserved healing of the intestinal mucosa, with mild hyperaemia and linear ulceration and no significant inflammation (Fig. 3C ). Long-term high-dose combined application NAC therapy gave the best morphological results (Fig. 4) .
The histological scores obtained from the short-(groups 3 -8) and long-term (groups 11 -16) groups were compared with those from untreated animals (groups 1, 2, 9, 10 and 17). High-dose long-term NAC therapy significantly (P < 0.05) reduced the histological scores: 3.0 ± 1.58 (group 14), 2.4 ± 0.54 (group 15) and 0.4 ± 0.89 (group 16) versus 0 (group 17; Fig. 4 ).
COLON MYELOPEROXIDASE ACTIVITY
Intracolonic administration of acetic acid caused an increase in MPO activity, which is a strong indicator of neutrophil accumulation in the colon. NAC treatment reversed this effect after both short-and longterm administration, and high and low dosages ( Fig. 5 ). MPO activity was higher in the short-term NAC-administered groups (groups 3 -8). The most notable decrease in MPO was seen in the long-term high-dose combined administration therapy group: 0.44 ± 0.36 U/g tissue (group 14), 0.45 ± 0.33 U/g tissue (group 15), 0.14 ± 0.09 U/g tissue : Effects of Nacetylcysteine treatment on the histological colon damage scores assigned to each sample from rats with experimentally induced colitis by an experienced histologist, using the criteria described in Table 3 . Error bars show the 95% confidence interval of the mean. * and º denote values outside normal distribution. The treatments received by each group of rats (1 -17) are shown in Table 1 
COLON GLUTATHIONE CONCENTRATION
Glutathione concentration in colon tissue showed a tendency to decrease in the shortterm high-dose NAC therapy groups compared with controls: 1.12 ± 0.14 µmol/g tissue (group 6), 1.15 ± 0.08 µmol/g tissue (group 7), 1.15 ± 0.15 µmol/g tissue (group 8) versus 1.57 ± 0.19 µmol/g tissue (group 17; Fig. 6 ). Results from the long-term therapy groups were not statistically different to those of rats given no therapy after colitis induction, however: 1.25 ± 0.08 µmol/g tissue (group 9) versus 1.28 ± 0.26 µmol/g tissue (group 16; Fig. 6 ).
COLON NITRIC OXIDE CONCENTRATION
Nitric oxide concentration in colon tissue showed a significant increase after shortterm high-dose NAC therapy: 0.33 ± 0.05 µmol nitrite/g tissue (group 6), 0.36 ± 0.04 µmol nitrite/g tissue (group 7), 0.39 ± 0.04 µmol nitrite/g tissue (group 8) versus 0.29 ± 0.15 µmol nitrite/g tissue (group 17; P < 0.05). With long-term treatment, however, NO did not change significantly: 0.27 ± 0.07 µmol nitrite/g tissue (group 14), 0.26 ± 0.08 µmol nitrite/g tissue (group 15), 0.32 ± 0.08 µmol nitrite/g tissue (group 16) versus 0.26 ± 0.09 µmol nitrite/g tissue (group 17). The highest NO concentrations were seen in the short-term high-dose combined administration treatment group Groups Effects of N-acetylcysteine on experimental colitis (group 8; 0.324 ± 0.08 µmol nitrite/g tissue; Fig. 7 ).
Discussion
Drugs currently used to manage human IBD generally exert their beneficial effects through a combination of different mechanisms. 9 Unfortunately, these drugs (i.e. compounds delivering 5-aminosalicylic acid and systemic or local glucocorticoids) have potentially serious side-effects that limit their use. 9 Developing new drug treatment is, therefore, an important goal in treating IBD. We evaluated the ability of NAC to accelerate mucosal repair after induced colonic damage, paying special attention to its effects on colonic oxidative stress and the production of some inflammatory response mediators.
N-Acetylcysteine is an antioxidant that reacts best with the hydroxyl radical and hypochlorous acid, but is poorly reactive with hydrogen peroxide and the superoxide radical. 5 NAC may also exert its antioxidant effect indirectly by facilitating GSH biosynthesis and supplying GSH for glutathione peroxidase-catalysed reactions. This drug has been used in a variety of disease states, including pulmonary oxygen toxicity, paracetamol toxicity and human immunodeficiency virus infection, as well as for treating ischaemic damage and toxicity in the lungs and liver, and in experimental ischaemic skin flaps. 9 As an antioxidant, NAC is widely used in clinical practice. Its potential protective effects in models of colitis had not been studied, however; we investigated these protective effects in an animal model by inducing tissue damage with acetic acid.
The intensive actions of various antioxidant enzymes that maintain a relatively low concentration of free radicals in cells are overwhelmed in states of oxidative stress. In the colonic mucosa, the tissue concentrations of endogenous antioxidants are low, so any oxidative stress may overwhelm the endogenous defences regulating ROS production. To aid the usual biodefences, a number of antioxidants are known to scavenge free radicals after they have formed. 3 Over the past decade, a wealth of evidence has been generated to support a crucial role for neutrophils in the pathogenesis of colitis. Evidence that colonic neutrophil infiltrates contribute to the progression of colitis stems from a series of clinical studies. In these studies an increased neutrophil accumulation was observed in rectal biopsies of patients with active IBD compared with healthy controls. 10 -12 Furthermore, a series of animal studies has associated colonic neutrophilia with the progression of acute colitis. 13 Colitis caused by acetic acid was characterized by an increase in MPO activity, an indicator of infiltration (accumulation) into the colon by polymorphonuclear neutrophils. 6 The histopathological and macroscopic scores we obtained when assessing colonic damage in the vehicletreated rat groups (groups 2 and 10) suggest the presence of a large number of polymorphonuclear neutrophils. Long-term treatment with a high NAC dose significantly reduced both the degree of polymorphonuclear neutrophil infiltration (determined as a decrease in MPO activity and histopathological and macroscopic scores) and tissue thickness, however.
In addition to anti-inflammatory effects, antioxidants act by preventing the formation of ROS (inhibitory effect) and/or by trapping these species (scavenger effect). GSH is a naturally occurring tripeptide whose nucleophilic and reducing properties play a central role in metabolic pathways as well as in the antioxidant system of most E Akgun, C Çaliskan, HA Celik et al.
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aerobic cells. 14 It functions as an endogenous hydroxyl radical scavenger 15 and as a substrate in the GSH redox cycle and in other xenobiotic elimination reactions. 16 This tripeptide is present in high concentrations in the liver. 17 An earlier study proposed that change in hepatic GSH concentration is an indicator of post-ischaemic hepatic injury. 17 Several reports indicate that tissue injury, induced by various stimuli, is coupled with GSH depletion. Depletion of renal GSH is one of the primary factors permitting lipid and protein oxidation. 18 It was reported that tissue GSH concentrations and the activities of glutathione reductase and glutathione peroxidase, which are critical constituents of the GSH-redox cycle, were significantly reduced by oxidative stress; the authors proposed that impairment of antioxidant defence mechanisms could permit enhanced free radical-induced tissue damage. Likewise, our study showed depletion of colon tissue GSH in the short-term treatment groups, which was restored in the long-term NAC therapy groups.
The gastrointestinal mucosa serves as the interface between the luminal contents and submucosal structures. The epithelium is defended against injury by several mechanisms, including epithelial intracellular pH regulation, blood flow and mucus gel secretion. Two studies have highlighted the importance of the nitrite anion in human biology. 19, 20 Our data have shown that NO concentration increased with short-term NAC therapy, whereas long-term NAC treatment prevented the accumulation of NO. Long-term NAC therapy may be useful for limiting acid damage to the superficial parts of the colonic mucosa, therefore. These results also indicate that NO elevation is an early event in colitis.
Our results suggest that in vivo administration of NAC for 7 days may reverse the oxidative stress occurring in experimentally induced colitis. Our rat experiments suggest potentially therapeutic benefits for NAC therapy as it significantly decreased colon tissue MPO activity and restored GSH and NO concentrations. Macroscopic and histological findings also support a protective role for NAC. It is likely that NAC, because of its actions as a free radical scavenger and antioxidant, merits consideration as a potential therapeutic agent for treating colitis. Overall, the effects of NAC we observed on redox enzyme activities and the NO pathway deserve further research in studies investigating the pathophysiology and management of gastrointestinal mucosal damage.
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